COMP <GO>
ERAS vs COGT // FREE CASH FLOW YIELD
Erasca Inc. (NASDAQ) VS. Cogent Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: ERAS 1
— COGT 3
▲ FREE CASH FLOW YIELD LEADER: ERAS
LAST: $14.05 (-2.09%) • MKT CAP: $5.02B
fcf-yield
-1.82%
LAST: $29.73 (-4.16%) • MKT CAP: $5.38B
fcf-yield
-4.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ERAS VS. COGT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ERAS | COGT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -1.82% | -4.80% | +2.98 | ERAS | /fcf-yield <GO> |
| Operating Margin | — | -21.50% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -21.20% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 22.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 10.84 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | COGT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.3 | 47.2 | -1.90 | COGT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.05 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 22.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.02B | $5.38B | -$363.7M | COGT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ERAS REV | COGT REV | ERAS GROSS % | COGT GROSS % | ERAS FCF | COGT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $394.5M | $933.4M | — | — | -$95.6M | -$266.0M |
| FY 2024 | $502.8M | $772.6M | — | — | -$109.5M | -$208.4M |
| FY 2023 | $396.3M | $582.8M | — | — | -$101.2M | -$153.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ERAS // BETA —
COGT // BETA 1.05